The final (to-date) alteration to the ACH2.0 is a notion that, after all, AβPP is produced (though it cannot be processed proteolytically due to the deficiency of gamma-secretase) in the AD-affected neurons not conventionally, but rather in a neuronal ISR-driven and ISR-compatible process. Here, APP is linked to Alzheimer disease.